Home / News / World News / Article / Israel's Institute completes development phase of COVID-19 antibodies

Israel's Institute completes development phase of COVID-19 antibodies

IIBR is now working to patent its antibody and secure a contract for its commercial development. All legal procedures will be coordinated with the Defence Ministry

  • WhatsAppBookmarkBookmark
Listen to this article :
This picture has been used for representation purpose

This picture has been used for representation purpose

Israeli Defence Minister Naftali Bennett on Monday said he witnessed a "significant breakthrough" by the country's biological research institute in developing an antibody to COVID-19 infection. Bennett visited the labs of the Israel Institute for Biological Research (IIBR), a secretive unit that works under the Prime Minister's Office, in Ness Ziona and was briefed by the research team, who revealed that the development phase of COVID-19 antibody or passive vaccine that attacks the virus and neutralizes it in the body has been complete, his office said in a statement cited by The Jerusalem Post.

IIBR is now working to patent its antibody and secure a contract for its commercial development. All legal procedures will be coordinated with the Defence Ministry. "I am proud of the Biological Institute staff, who have made a major breakthrough," Bennett was quoted as saying. "The Jewish creativity and ingenuity brought about this amazing achievement," he added.

Read Next Story
Donald Trump thinks COVID-19 fight's over?›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All